Browsing Tag
NPX-5
2 posts
What NPX-5’s Phase IIb trial means for the future of oncology-linked mental health treatments
NPX-5 enters Phase IIb trials for cancer-related mental health. Discover what this means for biotech strategy, regulation, and future treatments.
April 25, 2026
GMP psilocybin manufacturing supports growing psychedelic clinical pipeline
Psyence Biomedical Ltd. exports GMP psilocybin for a Phase IIb cancer trial. Discover what this means for psychedelic medicine and biotech investors.
March 6, 2026